MedPath

Cyclophosphamide

These highlights do not include all the information needed to use CYCLOPHOSPHAMIDE safely and effectively. See full prescribing information for CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE for injection, for intravenous useInitial U.S. Approval: 1959

Approved
Approval ID

8627c83f-c057-495d-9f78-8b67bda97b3e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 31, 2022

Manufacturers
FDA

Civica, Inc.

DUNS: 081373942

Products 3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

cyclophosphamide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72572-087
Application NumberANDA040745
Product Classification
M
Marketing Category
C73584
G
Generic Name
cyclophosphamide
Product Specifications
Route of AdministrationINTRAVENOUS, ORAL
Effective DateJuly 31, 2022
FDA Product Classification

INGREDIENTS (1)

CYCLOPHOSPHAMIDEActive
Quantity: 500 mg in 25 mL
Code: 8N3DW7272P
Classification: ACTIM

cyclophosphamide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72572-085
Application NumberANDA040745
Product Classification
M
Marketing Category
C73584
G
Generic Name
cyclophosphamide
Product Specifications
Route of AdministrationINTRAVENOUS, ORAL
Effective DateJuly 31, 2022
FDA Product Classification

INGREDIENTS (1)

CYCLOPHOSPHAMIDEActive
Quantity: 1 g in 50 mL
Code: 8N3DW7272P
Classification: ACTIM

cyclophosphamide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72572-083
Application NumberANDA040745
Product Classification
M
Marketing Category
C73584
G
Generic Name
cyclophosphamide
Product Specifications
Route of AdministrationINTRAVENOUS, ORAL
Effective DateJuly 31, 2022
FDA Product Classification

INGREDIENTS (1)

CYCLOPHOSPHAMIDEActive
Quantity: 2 g in 100 mL
Code: 8N3DW7272P
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Cyclophosphamide - FDA Drug Approval Details